Consequently, alterations of the endocrine regulatory pathways due to upregulation of hypothalamic/pituitary CXCL12/CXCR4 axis might lead to the development of pituitary adenomas [127, 129]. The gene discussed is CXCL12; the disease is pituitary gland adenoma.